MNKD

MannKind Corporation

3.58 USD
+0.03 (+0.85%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

MannKind Corporation stock is up 6.87% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 19 February’s closed higher than January. In the last 9 Unusual Options Trades, there were 3 CALLs, 6 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
02 Jan 15:43 17 Jan, 2025 4.00 CALL 312 219
02 Jan 16:12 17 Jan, 2025 4.00 PUT 674 185
02 Jan 16:12 17 Jan, 2025 4.00 PUT 348 185
02 Jan 16:13 17 Jan, 2025 4.00 PUT 1522 185
02 Jan 18:28 17 Jan, 2025 7.00 CALL 1497 3066
02 Jan 18:31 17 Jan, 2025 4.00 PUT 354 185
02 Jan 18:31 17 Jan, 2025 4.00 PUT 648 185
08 Jan 14:59 17 Jan, 2025 4.00 PUT 589 7845
08 Jan 15:14 17 Jan, 2025 4.00 CALL 418 3039

About MannKind Corporation

MannKind focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism.